Status:
COMPLETED
Sensitivity and Reproducibility of 18F-fluorodeoxyglucose Positron Emission Tomography for Assessment of Respiratory Muscle Activity
Lead Sponsor:
Institut de Myologie, France
Conditions:
Respiratory Muscle
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The assessment of respiratory muscle function is critical within both clinical and research settings. Tools for the assessment of respiratory muscle function are especially useful in diagnosing, pheno...
Detailed Description
The assessment of respiratory muscle function is critical within both clinical and research settings. Tools for the assessment of respiratory muscle function are especially useful in diagnosing, pheno...
Eligibility Criteria
Inclusion
- Age \> 18 yo
- Non-smoker
- Signed informed consent
- Affiliate or beneficiary of a social security scheme
- Non-
- Pregnant or breastfeeding women
- Respiratory, cardiovascular, metabolic, neuromuscular pathologies
- Claustrophobia
- Belonephobia
- Latex allergy
- Persons subject to a legal protection measure or unable to express their consent
- Contraindications to MRI (claustrophobia, metal implants)
- Inability to participate in the study
- Inability to comply with protocol requirements
Exclusion
- Blood sugar\> 1.8 g / L (V1, V2, V3)
- Impossibility of inserting the esophageal and / or gastric tubes (V2, V3)
Key Trial Info
Start Date :
May 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05234099
Start Date
May 5 2022
End Date
December 22 2023
Last Update
April 10 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Service hospitalier Fréderic Joliot
Orsay, France, 91400
2
Association Institut de Myologie
Paris, France, 75013